NCT06433869 2024-05-30The Efficacy of Bevacizumab and Serplulimab Combined With Recombinant Mutant HumanTumor Necrosis Factor(rmhTNF-NC) in the Treatment of Malignant AscitesSun Yat-sen UniversityPhase 2 Recruiting60 enrolled